Pages

Monday, December 9, 2019

Anti-diabetes drug Vildgliptin to become 80% cheaper

Anti-diabetes drug Vildgliptin to become 80% cheaper The patents for Vildagliptin in India held by Novartis were expired on December 9, opening the market for cheap rip-offs.

from Moneycontrol Business News https://ift.tt/346M903

No comments:

Post a Comment